Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 20, 2019
NJII has signed an Industry Participation Agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab.
read more
Wednesday, August 26, 2020
Rain Therapeutics has announced the signing of an agreement of a Drexel research program for small molecule inhibitors of RAD52.
read more
Catalent’s OptiDose Design Solution, led by Catalent’s scientific advisors, uses a design approach that combines data-driven scientific tools with Catalent’s extensive development expertise. Integrating pharmaceutics, and dose form design target ...
read more
Somerset, NJ – March 15, 2012 – Catalent Pharma Solutions, a leading global industry partner in product development, delivery and supply has extensive expertise in bringing more products to more markets around the world and will present a series of ...
read more
Wednesday, April 19, 2017
IntegriChain has announced the acquisition of PharmaMetrics, a provider of contract operations outsourcing and market access analytics software and services. The acquisition strengthens IntegriChain's ability to deliver industry-leading analytics and...
read more
SCIENTURE HOLDINGS announced the initiation of supply chain activities by its wholly owned subsidiary Scienture, LLC to manufacture launch quantities of Arbli™ (losartan potassium) Oral Suspension, 10 mg/mL for the intended commercial launch of the ...
read more
Amgen has announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I.
read more
Crown Bioscience has enhanced its existing portfolio of humanized drug target models by launching a new transgenic CD3E model to advance development of immuno-oncology drugs.
read more
Tuesday, December 08, 2015
Marken has announced the completion of their newest fully owned depot in Moscow for both clinical and commercial pharmaceutical drug storage, clinical trial services and distribution.
read more
Tuesday, February 11, 2025
Frontier Scientific Solutions announced that construction of its state-of-the-art cGMP temperature-controlled facilities at Wilmington International Airport (ILM) is in full swing with the first vertical structures being installed. This ...
read more
Hongene Biotech Corporation announced its role in advancing DNV001, a novel GalNAc-conjugated siRNA targeting dyslipidemia. The therapy, developed by Hangzhou Dingle Xinwei Biotechnology, recently received investigational new drug (IND) clearance ...
read more
Tuesday, November 17, 2020
PhoreMost and Oxford Biomedica have entered into a discovery collaboration to develop next-generation CAR-T cell therapies.
read more
Monday, December 18, 2017
The Board of Directors of bioMérieux have approved the appointment of Alexandre Mérieux as Chairman and CEO of the Company, effective immediately.
read more
Sanofi and REVOLUTION Medicines announced an exclusive worldwide partnership to develop and commercialize targeted therapies, based on the biology of the cellular enzyme SHP2.
read more
Cryoport, Inc. a temperature-controlled logistics company serving the life sciences industry, has initiated a novel and comprehensive logistics study to evaluate the impact of temperature and transport packaging at deep frozen temperatures on ...
read more